DE602004016834D1 - Zusammensetzung zur vermeidung und behandlung von cellulitis - Google Patents

Zusammensetzung zur vermeidung und behandlung von cellulitis

Info

Publication number
DE602004016834D1
DE602004016834D1 DE602004016834T DE602004016834T DE602004016834D1 DE 602004016834 D1 DE602004016834 D1 DE 602004016834D1 DE 602004016834 T DE602004016834 T DE 602004016834T DE 602004016834 T DE602004016834 T DE 602004016834T DE 602004016834 D1 DE602004016834 D1 DE 602004016834D1
Authority
DE
Germany
Prior art keywords
composition
cellulitis
avoidance
treatment
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004016834T
Other languages
English (en)
Inventor
Anton Jose Maria Garcia
Puche Juan Cebrian
Valles Alejandro Jose Germa
Elena Passerini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipotec SA
Original Assignee
Lipotec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec SA filed Critical Lipotec SA
Publication of DE602004016834D1 publication Critical patent/DE602004016834D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
DE602004016834T 2003-04-01 2004-03-18 Zusammensetzung zur vermeidung und behandlung von cellulitis Expired - Lifetime DE602004016834D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200300770A ES2228245B1 (es) 2003-04-01 2003-04-01 Composicion para la prevencion y el tratamiento de la celulitis.
PCT/ES2004/000126 WO2004087191A1 (es) 2003-04-01 2004-03-18 Composición para la prevención y el tratamiento de la celulitis

Publications (1)

Publication Number Publication Date
DE602004016834D1 true DE602004016834D1 (de) 2008-11-13

Family

ID=33104267

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004016834T Expired - Lifetime DE602004016834D1 (de) 2003-04-01 2004-03-18 Zusammensetzung zur vermeidung und behandlung von cellulitis

Country Status (14)

Country Link
US (1) US20070031516A1 (de)
EP (1) EP1611898B9 (de)
JP (1) JP2006522074A (de)
KR (1) KR20050107820A (de)
CN (1) CN100366287C (de)
AT (1) ATE409492T1 (de)
AU (1) AU2004226667A1 (de)
BR (1) BRPI0408948B1 (de)
CA (1) CA2520582A1 (de)
DE (1) DE602004016834D1 (de)
ES (2) ES2228245B1 (de)
MX (1) MXPA05010297A (de)
PL (1) PL1611898T3 (de)
WO (1) WO2004087191A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878851B1 (fr) * 2004-12-02 2007-02-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation en cryochirurgie et/ou cryopreservation
ES2342754B1 (es) 2008-10-03 2011-05-11 Lipotec, S.A. Peptidos utiles en el tratamiento y/o cuidado de la piel, mucosas, cuero cabelludo y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
US20110217252A1 (en) * 2008-11-11 2011-09-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
WO2010112084A1 (en) * 2009-04-03 2010-10-07 Oriflame Cosmetics Sa Topical cosmetic compositions for treating or preventing cellulite
JP5451558B2 (ja) * 2010-08-27 2014-03-26 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 美容活性成分の送達に有用なゲル
KR101033116B1 (ko) 2010-12-29 2011-05-11 주식회사 하나스포츠 다이어트용 카페인 테이프
CA2830069C (en) 2011-03-20 2019-11-12 The University Of British Columbia Therapeutic agent for emphysema and copd
EP2793813A1 (de) * 2011-12-21 2014-10-29 Motolese, Pasquale Kosmetische zusammensetzung und ihre verwendung bei der behandlung von lipodystrophien
JP6552079B2 (ja) * 2013-09-30 2019-07-31 ロート製薬株式会社 頭臭抑制用組成物
CN105534965A (zh) * 2015-12-11 2016-05-04 长顺县潘九妹养殖有限公司 尿素在手术治疗牲畜急性蜂窝织炎中的应用方法
JP6732495B2 (ja) * 2016-03-30 2020-07-29 小林製薬株式会社 皮脂分泌抑制用組成物
JP7089145B2 (ja) * 2017-09-29 2022-06-22 ロート製薬株式会社 痩身用外用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85643A1 (fr) * 1984-11-16 1986-06-04 Oreal Composition cosmetique thermo-amincissante a base d'extraits vegetaux oleosolubles
FR2671487B1 (fr) * 1991-01-14 1993-03-19 Oreal Utilisation d'un facteur de croissance dans une composition amincissante.
DE4244418A1 (en) * 1991-12-30 1993-07-01 Gerhard Quelle Cosmetic and pharmaceutical compsn. contg. specific tri:peptide(s) - is prepd. by controlled hydrolysis of collagen, etc., for stimulating cell respiration or collagen synthesis, etc.
DE4244415A1 (de) * 1992-12-29 1994-06-30 Gerhard Quelle Peptid-Präparate und Verfahren zu deren Herstellung
FR2740681B1 (fr) * 1995-11-07 1998-01-23 Fabre Pierre Dermo Cosmetique Composition cosmetique a base d'un extrait de viburnum
US20040146539A1 (en) * 2003-01-24 2004-07-29 Gupta Shyam K. Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits

Also Published As

Publication number Publication date
CN1767846A (zh) 2006-05-03
ES2228245A1 (es) 2005-04-01
PL1611898T3 (pl) 2009-05-29
MXPA05010297A (es) 2006-02-08
ES2228245B1 (es) 2006-06-01
EP1611898B9 (de) 2009-03-11
JP2006522074A (ja) 2006-09-28
KR20050107820A (ko) 2005-11-15
ES2315649T3 (es) 2009-04-01
CA2520582A1 (en) 2004-10-14
BRPI0408948B1 (pt) 2016-02-10
BRPI0408948A (pt) 2006-04-04
EP1611898B1 (de) 2008-10-01
ATE409492T1 (de) 2008-10-15
WO2004087191A1 (es) 2004-10-14
AU2004226667A1 (en) 2004-10-14
EP1611898A1 (de) 2006-01-04
CN100366287C (zh) 2008-02-06
US20070031516A1 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
FR2784029B1 (fr) Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie
DE602004016834D1 (de) Zusammensetzung zur vermeidung und behandlung von cellulitis
WO2003044053A3 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
WO2003008443A3 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
BR9704843B1 (pt) hidroxifeniltriazinas, composiÇço, processo de estabilizaÇço de material orgÂnico, uso, preparaÇço cosmÉtica e processo de tratamento de cabelo humano.
ES2160485A1 (es) Peptidos inhibidores de la exorcitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
US5766614A (en) Burn treatment compositions containing herbal mix
WO2002080876A3 (fr) Utilisation d'un extrait d'algue phaeodactylum pour favoriser l'activite du proteasome des cellules de la peau
WO2000002544A3 (en) Use of piperine for treating skin pigmentation disorders
WO2002097030A3 (en) Peptides derived from neural thread proteins and their medical use
EP1074245A3 (de) Mineralsalz enthaltende Zusammensetzung für eine therapeutische Behandlung
FR2768343B1 (fr) Utilisation d'au moins un extrait d'au moins un vegetal du genre chrysanthemum pour favoriser la pigmentation de la peau et/ou des cheveux
ATE237341T1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l- carnitin derivate und ginkgo biloba extrakte
IL141064A (en) Use of tnf-derived peptides for the manufacture of a medicament for treating oedema
WO2005009456A3 (fr) Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l’alopecie
GB9802078D0 (en) Preparation for treatment of erectile dysfunction
WO2005010027A3 (fr) Nouveaux conjugues peptidiques utiles dans le traitement preventif et curatif de l’alopecie
CA2309456A1 (en) .alpha.-amides of l-amino acids as fragrance precursors
EP1714979A3 (de) Peptide für die Behandlung von Tumoren und anderen Zuständen, die das entfernen oder zerstören von Zellen erfordern
DE60122120D1 (de) Zusammensetzung bestehend aus propionyl l-carnitine und glycine zur verhinderung und/oder behandlung von zytotoxischen effekten infolge der verwendung von immunsuppressiven
EP1847550A3 (de) Peptide zur effektiven Behandlung von Tumoren und anderen Bedingungen, die Zellentfernung oder- zerstörung erfordern
RU98114982A (ru) Состав, содержащий диосгенин
CA2428735A1 (en) Cosmetic compositions for improving the health of nails
BR0205412A (pt) Composição tÈnica natural para tratamento capilar
UA20073A (uk) Коhцеhтрат для косметичhих композицій та спосіб його одержаhhя

Legal Events

Date Code Title Description
8364 No opposition during term of opposition